BioWorld. Link to homepage.
BioWorld
BioWorld Science
BioWorld Asia
Data Snapshots
Biopharma
Medical technology
Infographics: Dynamic digital data analysis
Index insights
NME Digest
Special reports
Infographics: Dynamic digital data analysis
Ebola outbreak
Hantavirus
Trump administration impacts
Med-tech outlook 2026
Under threat: mRNA vaccine research
BioWorld at 35
Biopharma M&A scorecard
Bioworld 2025 review
BioWorld MedTech 2025 review
BioWorld Science 2025 review
Women's health
China's GLP-1 landscape
PFA re-energizes afib market
China CAR T
Alzheimer's disease
Coronavirus
More reports can be found here
BioWorld. Link to homepage.
Sign In
Sign Out
My Account
Subscribe
BioWorld - Wednesday, June 3, 2026
Home
»
Newsletters
» BioWorld Science
BioWorld Science
Feb. 13, 2017
View Archived Issues
AVEO Oncology reports clinical, regulatory progress with tivozanib
Read More
Cellceutix initiates main clinical site for phase IIa trial of Kevetrin
Read More
Hybrigenics presents preliminary results of phase II trial of inecalcitol in patients with CML
Read More
Phase I/II results for VM-202 in subjects with amyotrophic lateral sclerosis
Read More
Seattle Genetics and Immunomedics enter global license agreement for sacituzumab govitecan
Read More
Two-year data for trans-sodium crocetinate plus temozolomide and RT in glioblastoma multiforme
Read More
Merck Sharp & Dohme begins phase I testing of MK-1454 in advanced solid tumors, lymphomas
Read More
New autism research center established at MIT
Read More
Reckitt Benckiser to acquire Mead Johnson Nutrition
Read More
Alexo initiates phase I testing of ALX-148
Read More
Hutchison MediPharma initiates first-in-human study of HMPL-453
Read More
Cancer Research UK announces the first recipients of its global Grand Challenge competition
Read More
MMJ PhytoTech announces phase II study of PTL-101 to treat refractory epilepsy in children
Read More
TP53 gene mutations linked to lower survival after stem cell transplant for myelodysplastic syndrome
Read More
Novartis files for Japanese approval of Tasigna in pediatric CML
Read More
Acacia reports results from final pivotal trial of Baremsis for rescue treatment of PONV
Read More
STADA Arzneimittel confirms expressions of interest in company
Read More
Furaprevir phase II study completed successfully in Taiwan
Read More
GlaxoSmithKline reflects on highlights of fourth quarter 2016
Read More
